![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biostar Pharmaceuticals Inc (CE) | USOTC:BSPM | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
Maryland
(State or other jurisdiction
of incorporation or organization)
|
20-5101287
(I.R.S. Employer
Identification No.)
|
Large accelerated filer
o
|
Accelerated filer
o
|
||
Non-accelerated filer
o
|
Smaller reporting company
x
|
||
(Do not check if a smaller reporting company)
|
Title of securities to be registered
|
Amount
to be registered(1)
|
Proposed
maximum
offering price per
share(2)
|
Proposed maximum
aggregate offering
price(2)
|
Amount of
registration fee
|
||||||||||||
Common Stock, par value $0.001 per share
|
1,150,000 | $ | 1.44 | $ | 1,656,000 | $ | 213.29 |
(1)
|
The number of shares being registered represents the aggregate number of shares of common stock of the Company issuable under the 2013 Equity Incentive Plan (the “2013 Plan”). Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement also covers any additional shares of the Company common stock that may be granted under the Plan to prevent dilution resulting from stock splits, stock dividends or similar transactions.
|
(2)
|
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) under the Securities Act, based on the average of the high and low selling prices of the Company’s common stock as reported on the Nasdaq Stock Market on July 15, 2014.
|
BIOSTAR PHARMACEUTICALS, INC.
(Registrant)
|
|||
Date: July 17, 2014
|
By:
|
/s/ Ronghua Wang
|
|
Ronghua Wang
Chief Executive Officer and President
(Principal Executive Officer)
|
Date: July 17, 2014
|
By:
|
/s/ Qinghua Liu
|
|
Qinghua Liu
Interim Chief Financial Officer
(Principal Financial and Accounting Officer)
|
Date: July 17, 2014
|
By:
|
/s/ Qinghua Liu
|
|
Qinghua Liu, Interim Chief Financial Officer and Director
|
|||
Date: July 17, 2014
|
By:
|
/s/ Haipeng Wu
|
|
Haipeng Wu, Director
|
|||
Date: July 17, 2014
|
By:
|
/s/ King-fai Leung
|
|
King-fai Leung, Director
|
|||
Date: July 17, 2014
|
By:
|
/s/ Zhongyang Shang
|
|
Zhongyang Shang, Director
|
Exhibit
|
Description
|
|
4.1
|
||
4.2
|
Specimen common stock certificate (1)
|
|
5.1
|
||
23.1
|
||
23.2
|
1 Year Biostar Pharmaceuticals (CE) Chart |
1 Month Biostar Pharmaceuticals (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions